Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

An integrated design for dose comparison trials

P H Hsu1

  • 1Clinical Trials Section, Imagenetics, Naperville, IL 60566-7011.

Journal of Clinical Pharmacology
|August 1, 1993
PubMed
Summary

This study proposes an integrated design for drug trials to compare doses, especially for drugs with first-dose effects. The design allows for rational determination of optimal drug titration regimens by evaluating efficacy and safety together.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Waveforms of the ductus venosus blood flow in normal human fetuses aged 8-38 weeks.

Chang Gung medical journal·2002
Same author

Aprotinin, blood loss, and renal dysfunction in deep hypothermic circulatory arrest.

Circulation·2001
Same author

Prenatal sonographic appearance of Beare-Stevenson cutis gyrata syndrome: two- and three-dimensional ultrasonographic findings.

Prenatal diagnosis·2001
Same author

HER-2/neu gene amplification in stages I-IV breast cancer detected by fluorescent in situ hybridization.

Genetics in medicine : official journal of the American College of Medical Genetics·2001
Same author

Sorcin associates with the pore-forming subunit of voltage-dependent L-type Ca2+ channels.

The Journal of biological chemistry·1998
Same author

Quantitation of HER-2/neu and c-myc gene amplification in breast carcinoma using fluorescence in situ hybridization.

Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc·1997

Area of Science:

  • Clinical Trials Methodology
  • Pharmacology
  • Drug Development

Background:

  • Drugs causing a first-dose phenomenon require careful dose titration.
  • Existing parallel comparative designs may not adequately address dose-response and titration effects for such drugs.

Purpose of the Study:

  • To propose an integrated design for dose comparison trials that incorporates dose titration schemes.
  • To provide a valid estimate of drug effect using a concurrent placebo control group.
  • To enable rational determination of optimum titration regimens by evaluating efficacy and safety in the same patient group.

Main Methods:

  • An integrated design combining parallel comparative design with dose titration.
  • Inclusion of a concurrent placebo control group.
  • Standardized titration schedules and intervals, with maximum allowable doses defining other groups.

Main Results:

  • The design controls for the pace of titration, allowing assessment of various dose-related questions.
  • It facilitates evaluation of overall drug effects, starting dose adequacy, dose increments, maximum effective dose, dose-response relationships, and time effects.
  • Efficacy and safety analyses can be performed within the same patient groups for risk-benefit evaluation.

Conclusions:

  • The proposed integrated design is suitable for dose comparison trials of drugs with first-dose phenomena.
  • It allows for a comprehensive understanding of drug effects and dose-response relationships.
  • The design supports rational determination of optimal titration regimens and risk-benefit analysis.

Related Experiment Videos